Plain-English translation of NCT06675552 on ClinicalTrials.gov ↗ ·
This study is following patients hospitalized with a weakened heart (reduced ejection fraction) to see how well doctors can quickly start guideline-recommended heart failure medications during the hospital stay, and whether patients keep taking these medications after they go home. The researchers want to understand what helps patients stay on their medications and do better in real life.
Many heart failure patients benefit from four specific types of medications, but doctors don't always start all of them right away in the hospital, and patients sometimes stop taking them after discharge. This study aims to understand the best way to get patients on the right medications quickly and keep them on track at home.
You likely qualify if…
You likely don't qualify if…
You will be enrolled while you are in the hospital receiving treatment for heart failure. Researchers will track your medical care during your hospital stay and after you go home, collecting information about which medications you are prescribed, whether you take them, your symptoms, and how you are doing over time. There are no study visits or procedures beyond your normal care — the study team simply watches and records what happens in your regular treatment.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
Germany